Artificial Intelligence Is Future Of Postmarketing Surveillance, US FDA’s Marks Says
CBER director’s vision for a national safety surveillance system includes use of AI and natural language processing to enable near-real time signal detection from adverse event reports.
You may also be interested in...
CBER director Peter Marks also wants to work on rare disease gene therapy issues and increase hiring before the end of the year.
Head of agency’s inspectorate stresses need to invest in new IT infrastructure for manufacturing site inspections. New FDA Inspectional Affairs Council leads the charge.
President Biden’s budget request would add $1.63bn in mandatory funding to the FDA budget in FY 2023.